Phase 2 N=72 Nutrition and Body Composition in Acute Lymphoblastic Leukemia
Precursor Cell Lymphoblastic Leukemia-Lymphoma · Vitamin D Deficiency
Primary: Change in Serum Vitamin D Level (Group A) — 5.5; -0.30; 1.0; 26.5 ng/ml
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=202 RHA Redensity - Perioral Rhytids
Perioral Rhytids · Aging · Wrinkle
Primary: Change From Baseline in Perioral Rhytids Severity Rating Scale (PR-SRS) Score Rated by the Blinded Live Evaluator (BLE) at Week 8 After Last Treatment. — 121; 4; 29; 47…
Phase 1 N=31 A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients
Breastcancer
Primary: PK Parameters for paclitaxel_AUC (0-52) — 3419; 3224 ng*hr/mL
Phase 2 N=65 Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes
Myelodysplastic Syndromes
Primary: Overall Response Rate Based on the Modified International Working Group (IWG) 2006 Response Criteria for Myelodysplastic Syndrome (MDS) — 6.3; 4.5; 16.7; 0 Percentage of…
N/A N=29 Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions
Kaposi's Sarcoma
Primary: Preliminary Assessment of the Temperature of Kaposi's Sarcoma Lesions Compared to the Temperature in the Normal Skin Measured With Thermography — 1.1 Celsius
N/A N=256 Safety and Effectiveness Study of the Precision SCS Systems Adapted for High-Rate Spinal Cord Stimulation
Chronic Pain · Back Pain
Primary: Proportion of Responders as Determined by the Cumulative Distribution Function (CDF) of Response Rates — 0.47; 0.53; 0.4 probability
Phase 2 N=260 A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Primary: Systemic Lupus Erythematosus Responder Index (SRI)-4 Response at Week 48 — 44.2; 50.6; 51.7 Percentage of Participants — p=0.373
Phase 2 N=23 Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects
Depression
Primary: Montgomery-Asberg Depression Rating Scale — 27.9387; 26.5756; 16.5482; 20.9065 score on a scale
N/A N=3 Advanced Visuohaptic Surgical Planning for Trauma Surgery
Maxillofacial Injuries
Primary: Percentage of Deviation From Actual Surgical Outcome During Virtual Repair of Mandibular Fractures, Using the Novel Visuohaptic Computational Platform That Was Developed…
Phase 4 N=44 Renoprotective Effects of Dapagliflozin in Type 2 Diabetes
Diabetes Mellitus, Type 2 · Diabetic Nephropathies
Primary: Glomerular Filtration Rate (GFR) in ml/Min — 104; 109 ml/min
Phase 3 N=20 Early Use of Vasopressin in Post-Fontan Management
Circulatory Perfusion Disorder · Congenital Heart Disease · Single-ventricle
Primary: Hemodynamics as Characterized by Vasoactive Inotrope Score (VIS) — 11; 11.3 units
N/A N=53 Utilizing Telemedicine for Delivery of Postoperative Care
Laparoscopic Gynecologic Surgery
Primary: PSQ-18 General Satisfaction — 4.0; 4.5 score on a scale
Phase 3 N=300 Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency.
Growth Hormone Disorder · Adult Growth Hormone Deficiency
Primary: Change in Truncal Fat Percentage (Week 34) — 0.49; -2.39; -1.17 Percentage of truncal fat — p==0.0090
Phase 3 N=1,607 Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in Adults
Hepatitis B Vaccines
Primary: Seroprotection Rate (SPR) Defined as Percentage of Adults ≥ 18 Years Old Achieving Anti-HBs Levels of ≥10 mIU/mL in Serum at Study Day 196 — 76.49; 91.36 percentage of…
N/A N=183 Management of Myelomeningocele Study (MOMS)
Meningomyelocele · Spinal Dysraphism
Primary: Infant Death or Need for Ventricular Shunt by 1 Year of Life — 66; 90 Participants